Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Duarte

Showing results (641-650 of 680) with videos related to

Pageof 68
Sort By:
JAMA Network Open|January 25, 2022
Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent PlasmaHyung Park, Thaddeus Tarpey, Mengling Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Iscience|August 18, 2025
Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccineYohana Martínez-Balboa, Linmar Rodríguez-Guilarte, Constanza Méndez, et al.
Elife|October 13, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trialNicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz, et al.
Bone Marrow Transplantation|August 23, 2016
Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMTZ DeFilipp, R F Duarte, J A Snowden, et al.
BMC Medicine|December 15, 2025
A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunityConstanza Méndez, Linmar Rodríguez-Guilarte, Pablo A Palacios, et al.
Mbio|August 10, 2022
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of ConcernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2016
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMTZachariah DeFilipp, Rafael F Duarte, John A Snowden, et al.
Ebiomedicine|April 26, 2023
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adultsConstanza Méndez, Hernán F Peñaloza, Bárbara M Schultz, et al.
Lancet Regional Health. Americas|September 22, 2025
Active West Nile virus transmission in Brazil: an epidemiological studyShirlene T S de Lima, Ingra M Claro, Xinyi Hua, et al.
Pageof 68

Showing results (641-650 of 680) with videos related to

Sort By:
Pageof 68
JAMA Network Open|January 25, 2022
Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent PlasmaHyung Park, Thaddeus Tarpey, Mengling Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Iscience|August 18, 2025
Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccineYohana Martínez-Balboa, Linmar Rodríguez-Guilarte, Constanza Méndez, et al.
Elife|October 13, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trialNicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz, et al.
Bone Marrow Transplantation|August 23, 2016
Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMTZ DeFilipp, R F Duarte, J A Snowden, et al.
BMC Medicine|December 15, 2025
A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunityConstanza Méndez, Linmar Rodríguez-Guilarte, Pablo A Palacios, et al.
Mbio|August 10, 2022
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of ConcernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2016
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMTZachariah DeFilipp, Rafael F Duarte, John A Snowden, et al.
Ebiomedicine|April 26, 2023
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adultsConstanza Méndez, Hernán F Peñaloza, Bárbara M Schultz, et al.
Lancet Regional Health. Americas|September 22, 2025
Active West Nile virus transmission in Brazil: an epidemiological studyShirlene T S de Lima, Ingra M Claro, Xinyi Hua, et al.
Pageof 68